| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | -100.0% |
| R&D Expense | $13.0M | — | -34.4% |
| SG&A Expense | $7.5M | — | -4.4% |
| Operating Income | -$20.4M | — | +18.3% |
| Pre-tax Income | -$19.5M | — | +16.5% |
| Income Tax | $95K | — | — |
| Net Income | -$19.6M | — | +16.1% |
| EPS (Basic) | -$1.69 | — | +32.1% |
| EPS (Diluted) | -$1.69 | — | +32.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $61.7M | +182.7% | -3.8% |
| Short-term Investments | $52.3M | -2.0% | +2.9% |
| Accounts Receivable | $0 | -100.0% | -100.0% |
| Current Assets | $120.2M | +45.9% | -0.9% |
| Total Assets | $183.6M | +61.8% | -9.2% |
| Current Liabilities | $14.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$16.1M | — | +34.3% |
| Capital Expenditures | $21K | — | -82.4% |
| Investing Cash Flow | -$32.2M | — | -198.3% |
| Financing Cash Flow | $88.2M | — | — |
| Free Cash Flow | -$16.1M | — | +34.5% |
| +14.8% |
| Total Liabilities | $64.0M | +3.1% | +1.2% |
| Stockholders' Equity | $119.6M | +132.6% | -13.9% |